Literature DB >> 21508176

Pancreatic enzyme supplementation for patients receiving enteral feeds.

Suzie Ferrie1, Christie Graham, Matthew Hoyle.   

Abstract

BACKGROUND: Pancreatic enzyme supplementation is an important part of management for a number of gastrointestinal conditions. For patients who are unable to swallow pancreatin capsules or granules, enteral feeding tubes can be used to administer the pancreatic enzyme. This presents challenges given the unique format of the pancreatic enzyme supplements, with common problems including tube blockage and loss of the enzyme's effect. METHODS AND
RESULTS: A novel technique is described for administration of pancreatic enzyme via feeding tubes. For gastrically placed tubes, this involves opening the pancreatin capsules and suspending the enzyme microspheres in thickened acidic fluid (such as the mildly thickened or "nectar-thick" fruit juice used for dysphagia) for delivery into the feeding tube. This technique minimizes tube blockage by preventing the enzyme from clumping in the tube. For jejunally placed tubes, enzyme microspheres can be crushed and activated with sodium bicarbonate before flushing into the tube, or the activated enzyme mixture can be added to enteral feeds.
CONCLUSIONS: Pancreatic enzyme supplementation can continue while patients receive enteral feeding. Using the described technique can help to avoid tube blockage and maintain optimal enzyme activity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21508176     DOI: 10.1177/0884533611405537

Source DB:  PubMed          Journal:  Nutr Clin Pract        ISSN: 0884-5336            Impact factor:   3.080


  6 in total

1.  Significant Published Articles for Pharmacy Nutrition Support Practice in 2014 and 2015.

Authors:  Roland N Dickerson; Vanessa J Kumpf; Allison B Blackmer; Angela L Bingham; Anne M Tucker; Joseph V Ybarra; Michael D Kraft; Todd W Canada
Journal:  Hosp Pharm       Date:  2016-07

2.  Administration of CREON® pancrelipase pellets via gastrostomy tube is feasible with no loss of gastric resistance or lipase activity: an in vitro study.

Authors:  George Shlieout; Andreas Koerner; Mario Maffert; Kristin Forssmann; Steven Caras
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

Review 3.  Clinical Factors as a Component of the Personalized Treatment Approach to Advanced Pancreatic Cancer: a Systematic Literature Review.

Authors:  William Paul Skelton; Hiral Parekh; Jason S Starr; Jose Trevino; Jessica Cioffi; Steven Hughes; Thomas J George
Journal:  J Gastrointest Cancer       Date:  2018-03

4.  Pancrelipase: an evidence-based review of its use for treating pancreatic exocrine insufficiency.

Authors:  Kei Nakajima; Haruki Oshida; Toshitaka Muneyuki; Masafumi Kakei
Journal:  Core Evid       Date:  2012-07-19

Review 5.  Consensus for the management of pancreatic exocrine insufficiency: UK practical guidelines.

Authors:  Mary E Phillips; Andrew D Hopper; John S Leeds; Keith J Roberts; Laura McGeeney; Sinead N Duggan; Rajesh Kumar
Journal:  BMJ Open Gastroenterol       Date:  2021-06

6.  Crushing pancreatic enzymes with enteral feeds in an extremely premature infant with cystic fibrosis-a novel and effective technique.

Authors:  Jodi Grunert; Andrew Tai
Journal:  Eur J Clin Nutr       Date:  2020-08-28       Impact factor: 4.884

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.